About our project
The problem we solve: Healthcare/medicine is practiced in reaction to a recent injury or presentation of a longer term condition or disease.
Today imaging is used after a Physical Exam by a physician, as a confirmation of initial findings. Imaging is only applied to a very specific anatomy or area of interest based on a potential diagnosis.
About our solution:
Personalized digital physical exam to help predict disease risks, by directly assessing the vital organs & tissues from a whole body perspective,utilizing: non-invasive medical imaging to acquire data,automation algorithms to quantify images, and Artificial Intelligence to develop predictive analytics for improved health.
SAAS platform enables access to the latest imaging technology, and support for legacy scanners,while improving accuracy,precision,and standardization across imaging facilities.
Progress to
date:
-
Protocols are complete & ready to be installed on client scanners, while cloud analytics platform is ready to perform processing & provide deliverables/reports.
-
Platform comprised of different backend processing techniques. Client facing screens are for cloud based data uploading of imaging data. Library of disease focused risk prediction models under development & will grow with each scan prospective scan that is acquired and processed, along with any retrospective datasets that are analyzed.
About Our Team
Creator: Parth Agrawal
Location: Indiana
Bio: Parth is a Biomedical Engineer who has been trained in Project Management and Product Development. He is interested in the Healthcare applications of Deep Learning. He is well travelled and in his spare time loves to play Squash.
Title: Business Development
Advanced Degree(s): MS in Biomedical Technology, Master of Biomedical Innovation and Development
About Team Members
Mark Punyanitya
CEO, Vanderbilt University-Biomedical Engineering Columbia University-Master’s Applied Physiology New York University-Master’s Applied Clinical Trials
Biography: Imaging Expert – 15+ yrs of domain expertise in global multi-center clinical
trials utilizing quantitative imaging.
Founder of Image Reading Center, Inc. (an active Imaging Core Lab and Contract
Research Organization)
Title: CEO
Advanced Degree(s): Vanderbilt University-Biomedical Engineering Columbia University-Master’s Applied Physiology New York University-Master’s Applied Clinical Trials
Twitter:
@markpun
LinkedIn:
https://www.linkedin.com/in/markpun/
Zachary Rapp
COO, Columbia University-Master’s in Biotechnology & Entrepreneurship University of California, Berkeley, School of Law-Certificate 500 Startups VC Unlocked: Venture Capital & Early-Stage Investing Drew University-BA in Biological Anthropology
Biography: Entrepreneur, consultant, and advisor driven to architect and invest in
disruptive patient-centric & science-driven ventures.
5+ yrs in oncology and genetics drug discovery and development research.Co-
founded and licensed out enzyme replacement therapy to small-cap biopharma company.
Advises select life science companies, and has successfully assisted in raising
capital for early-stage ventures.
Title: COO
Advanced Degree(s): Columbia University-Master’s in Biotechnology & Entrepreneurship University of California, Berkeley, School of Law-Certificate 500 Startups VC Unlocked: Venture Capital & Early-Stage Investing Drew University-BA in Biological Anthropology
Twitter:
@zachary_rapp
LinkedIn:
https://www.linkedin.com/in/zacharyrapp/
Girish Srinivasan
CTO, University of Madras-Bachelor’s Degree Computer Engineering University at Buffalo-Master’s Degree Computer Science University of Illinois at Chicago-Doctor of Philosophy (Ph.D.) Bio Engineering, Medical Imaging
Biography: 13+ years Healthcare Solutions Leader, Clinical Research & Diagnostic
Applications & Platform. Former Samsung, GE, Toshiba.
Title: CTO
Advanced Degree(s): University of Madras-Bachelor’s Degree Computer Engineering University at Buffalo-Master’s Degree Computer Science University of Illinois at Chicago-Doctor of Philosophy (Ph.D.) Bio Engineering, Medical Imaging
Twitter:
@girisriniv1
LinkedIn:
https://www.linkedin.com/in/srinivasangirish
Andrew Bogle
Co-Founder, Vanderbilt University-MBA in Finance Connecticut College-BA in Economics
Biography: Active advisor and angel investor. Creating an angel fund among friends. Since
2010, has spent significant time with entrepreneurs connecting them to other
entrepreneurs, angel investors, advisors and potential clients of their business.
Serves on two non-proitt Boards and several corporate Advisory Boards.
Title: Co-Founder
Advanced Degree(s): Vanderbilt University-MBA in Finance Connecticut College-BA in Economics
Twitter:
@andrewbogle
LinkedIn:
https://www.linkedin.com/in/andrew-bogle-5b0641
About Our Company
PhenoMx
Location: 105 East 34th Street #148 New York NY
New York, 10016
Founded: 2017
Website: http://www.phenomx.co
Product
Stage: Ready
YTD Sales: Working on it
Employees: 5-10
How We Help Physicians
Personalized digital physical exam to help predict disease risks, by directly assessing the vital organs & tissues from a whole body perspective,utilizing: non-invasive medical imaging to acquire data,automation algorithms to quantify images, and Artificial Intelligence to develop predictive analytics for improved health.
SAAS platform enables access to the latest imaging technology, and support for legacy scanners,while improving accuracy,precision,and standardization across imaging facilities.
How We Help Partners
For Investors
We are addressing a combined market of $256B
b) these markets include the latest technical advances that are changing the future of healthcare and medicine
c) Combined market of $256B comprised of:
BIOMARKERS $97B (2020)
PRECISION MEDICINE $87B (2023)
MEDICAL IMAGING $46B (2022)
HEALTHCARE ANALYTICS $19B (2020)
MRI SYSTEMS $7B (2020)
Challenge Mission
Key Milestones Achieved and Planned
By end of Q1 2018 we would have done the following-
- Secured additional technology licenses and strategic partners
-
Initiated pilot/validation study with key opinion leader/institution
-
Secured initial client/customer (either biotech/pharma/CRO or health/wellness facility)
-
Further development of platform
We plan to do the following starting in Q3 2018
- Completion of retrospective study
-
Publication of clinical study validation
-
Submission of regulatory application
-
Strategic partnerships with pre-release partners
Our Competitive Advantages
-
Competitive Advantage- Unique technical expertise in installing & managing advanced imaging technologies to provide a quantitative approach that delivers insights from combined organ & tissue interaction. Unique market insight from experience/expertise evaluating imaging techniques and training hundreds of imaging facilities.
-
Novelty of technology- Typical imaging companies develop individual techniques that only focus on a single organ or tissue, while we are focused on providing a comprehensive solution beyond what any one single provider could offer.
-
No new stake holders.
Barriers to Entry
We currently hold an exclusive, worldwide, all domains of practice license for an algorithm to map scar tissue in the heart. We will be developing new IP based off of this core technology, as well as the integration of the different imaging technologies that we are and will be working with.
Traction, Funding and Partners
Current customer is IPMC in South Korea. 3 projects: 100 participants over a period of 1 year, offered for the residents of Paju city, supported by the Korean government.
Project 2: offer annual digital physical examination to employees of 2 large corporate customers
Project 3: Alzheimer’s moonshot project to diagnose, treat and prevent the occurrence of mental disorders
We are on discussions with replicating similar services for precision medicine in China, Middle East, US and Europe.
Innovation Details
Intellectual Property Summary
We currently hold an exclusive, worldwide, all domains of practice license for an algorithm to map scar tissue in the heart. We will be developing new IP based off of this core technology, as well as the integration of the different imaging technologies that we are and will be working with.
Clinical Information
Current customer is IPMC in South Korea. 3 projects: 100 participants over a period of 1 year, offered for the residents of Paju city, supported by the Korean government.
Project 2: offer annual digital physical examination to employees of 2 large corporate customers
Project 3: Alzheimer’s moonshot project to diagnose, treat and prevent the occurrence of mental disorders
We are on discussions with replicating similar services for precision medicine in China, Middle East, US and Europe.
Regulatory Status
No need for FDA clearance.
How we will use the funds raised
Product Development
Marketing
Operational Expenses
Thank You
PhenoMx was conceived by a group of accomplished industry veterans with experience managing the entire lifecycle of diagnostic image solutions, from early clinical to product management to end user. Our focus is advancing high value imaging of the whole body.
PhenoMx, enables innovators to enter, navigate, and grow related technology in the diagnostic imaging space through commercial partnership, licensing agreement, and subsidy arrangements.
Our team of industry veterans have amassed a significant amount of unique experiences and relationships that not only provide deep domain expertise in this specific market, but also allows for insight into upcoming trends in the R&D space, so that we are able to make valuable assessments of which technologies are appropriate for commercialization and further development in existing and new markets that we are creating.
